The preoperative percentage of IL-4-producing T cells from PBMC of patients with malignancy was significantly higher than in the control groups, while patients who underwent LC showed no significant differences from the healthy controls. This evidence concerns the gene IL4 and laryngotracheoesophageal cleft.